Identifying Frailty: Do the Frailty Index and Groningen Frailty Indicator Cover Different Clinical Perspectives? a Cross-sectional Study
Overview
Public Health
Authors
Affiliations
Background: Early identification of frailty is important for proactive primary care. Currently, however, there is no consensus on which measure to use. Therefore, we examined whether a Frailty Index (FI), based on ICPC-coded primary care data, and the Groningen Frailty Indicator (GFI) questionnaire identify the same older people as frail.
Methods: We conducted a cross-sectional, observational study of 1,580 patients aged ≥ 60 years in a Dutch primary care center. Patients received a GFI questionnaire and were surveyed on their baseline characteristics. Frailty-screening software calculated their FI score. The GFI and FI scores were compared as continuous and dichotomised measures.
Results: FI data were available for 1549 patients (98%). 663 patients (42%) returned their GFI questionnaire. Complete GFI and FI scores were available for 638 patients (40.4%), mean age 73.4 years, 52.8% female. There was a positive correlation between the GFI and the FI (Pearson's correlation coefficient 0.544). Using dichotomised scores, 84.3% of patients with a low FI score also had a low GFI score. In patients with a high FI score, 55.1% also had a high GFI score. A continuous FI score accurately predicted a dichotomised GFI score (AUC 0.78, 95% CI 0.74 to 0.82). Being widowed or divorced was an independent predictor of both a high GFI score in patients with a low FI score, and a high FI score in patients with a low GFI score.
Conclusions: The FI and the GFI moderately overlap in identifying frailty in community-dwelling older patients. To provide optimal proactive primary care, we suggest an initial FI screening in routine healthcare data, followed by a GFI questionnaire for patients with a high FI score or otherwise at high risk as the preferred two-step frailty screening process in primary care.
Duluklu B, Ivory J, McElvaney A, Bligh A, Cahill-Collins M, Gethin G Int Wound J. 2025; 22(1):e70119.
PMID: 39800366 PMC: 11725367. DOI: 10.1111/iwj.70119.
Jablonowska-Babij P, Olszewska-Szopa M, Potoczek S, Majcherek M, Szeremet A, Kujawa K Cancers (Basel). 2025; 16(24.
PMID: 39766069 PMC: 11674628. DOI: 10.3390/cancers16244170.
Kong J, Trinh K, Hammill K, Chia-Ming Chen C Biol Res Nurs. 2024; 26(4):526-536.
PMID: 38739714 PMC: 11439236. DOI: 10.1177/10998004241254459.
Evaluation of a new two-step frailty assessment of head and neck patients in a prospective cohort.
Padovan B, Bijl M, Langendijk J, van der Laan H, van Dijk B, Festen S Eur Arch Otorhinolaryngol. 2024; 281(8):4291-4304.
PMID: 38653824 PMC: 11266264. DOI: 10.1007/s00405-024-08651-8.
Frailty and Metabolic Vulnerability in Heart Failure: A Community Cohort Study.
Kumar S, Conners K, Shearer J, Joo J, Turecamo S, Sampson M J Am Heart Assoc. 2024; 13(8):e031616.
PMID: 38533960 PMC: 11262513. DOI: 10.1161/JAHA.123.031616.